FDA's drug center to consolidate AI efforts under single council

FDA's drug center to consolidate AI efforts under single council

Source: 
Fierce Biotech
snippet: 

The FDA’s Center for Drug Evaluation and Research (CDER) is consolidating its artificial-intelligence-related activities under a single AI Council, in part in response to efforts from the Biden administration to ensure the safety and security of machine learning software.